Showing results (2401-2410 of 4,523) with videos related to
Sort By:
Pageof 453
Advances in Therapy|March 29, 2025
The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without DiabetesChristopher Lübker, Jigish Bhavsar, Ruben Duque do Vale, et al.Advances in Therapy|June 17, 2025
Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: A Discrete Choice Experiment Among Patients in Five Non-Western CountriesMarjorie Argollo, Yoon K An, Nahla Azzam, et al.Advances in Therapy|June 19, 2025
A Randomized Phase I Trial Evaluating Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eclitasertib, a RIPK1 Inhibitor, in Healthy ParticipantsChristine Farenc, Pierre-Francois Clot, Salvatore Badalamenti, et al.Advances in Therapy|June 5, 2025
GLP-1 Receptor Agonists, DPP-4 Inhibitors and the Skin-Diabetes Meets Dermatology: A Brief Narrative ReviewDimitrios Pantazopoulos, Evanthia Gouveri, Massimo Papi, et al.Advances in Therapy|May 29, 2025
Economic Burden and Provider Referral Patterns Among Patients with Unresectable Stage III EGFR-Mutated NSCLC Receiving Chemoradiotherapy in the United StatesYongJin Kim, Yong Zhu, Kristin J Moore, et al.Advances in Therapy|June 7, 2025
An Overview of Currently Available Injectable Therapies in Diabetes: A Guide to PractitionersJothydev Kesavadev, Anjana Basanth, Arun Shankar, et al.Advances in Therapy|June 6, 2025
Sustained Metabolic Improvements with Low-Dose Metformin Combined with Oral Contraceptives in Female Adolescents with PCOS: A Single-Center Retrospective Cohort StudySalvatore Giovanni Vitale, Stefano Di Michele, Alice Tassi, et al.Advances in Therapy|May 22, 2025
Real-World Insights on Satisfaction and Experience with Acthar Gel via SelfJect (RISE™): A Cross-Sectional Patient SurveyJas Bindra, Ishveen Chopra, Kyle Hayes, et al.Advances in Therapy|May 19, 2025
Glycaemic and Weight Control in People Aged 65 or Younger Newly Diagnosed with Type 2 Diabetes in Spain: Insights from the PRIORITY-T2D StudyEmilio Ortega, Jennifer Redondo-Antón, Silvia Díaz-Cerezo, et al.Advances in Therapy|May 19, 2025
Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and TreatmentPenny Asbell, Esen Akpek, Winston Chamberlain, et al.Pageof 453